Results 231 to 240 of about 104,473 (343)
Analysis of Rectal Neoplasms Operated After Neoadjuvant Therapy in A Period of 10 Years
Humberto Fenner Lyra +6 more
openalex +2 more sources
Magnetic Resonance Guided Radiation Therapy (MRgRT) Prostate Motion and Margins
This study evaluated intra‐fractional prostate motion during MR‐guided radiotherapy to determine appropriate PTV margins for prostate cancer. Analysis of 18 patients resulted in calculated margins of 3.2 mm (AP), 1.7 mm (LR), and 3.2 mm (SI), supporting the potential for margin reduction with MRgRT. ABSTRACT Introduction Systematic and random errors in
Sammi Peng +7 more
wiley +1 more source
Age-specific trends in colorectal, appendiceal, and anal tumour incidence by histological subtype in Australia from 1990 to 2020: a population-based time-series analysis. [PDF]
Meyers AL +6 more
europepmc +1 more source
Dextran sodium sulfate confounds causal role of periodontitis in inflammatory bowel disease
Abstract Background Emerging evidence supports a bidirectional link between periodontitis and inflammatory bowel disease (IBD). To investigate this relationship, experimental models commonly use dextran sodium sulfate (DSS) to induce colitis. However, DSS is presumed to selectively affect the colon, and its potential off‐target effects on the oral ...
Himanshi Tanwar +11 more
wiley +1 more source
Colorectal clear cell carcinoma: a literature review. [PDF]
Salehi M +5 more
europepmc +1 more source
Abstract Children with inflammatory bowel diseases (IBD) have limited access to the available advanced therapies, given the lengthy gap between adult and pediatric approval. We aimed to review key hurdles for pediatric trials and recommend practical solutions.
Dan Turner +21 more
wiley +1 more source
Gastrointestinal stromal tumor of the rectum mimicking a prostatic mass: case report. [PDF]
El Hajjami A +4 more
europepmc +1 more source
Perioperative utilization of JAK inhibitors in Perianal Fistulizing Crohn's disease
Abstract With the recent approval of small molecule drugs such as upadacitinib in adult inflammatory bowel disease (IBD), their utilization is becoming more common; however, there is limited data on perioperative risks or optimal timing of cessation and resumption to mitigate flares. Current recommendations suggest holding these medications for 14 days
Alexander Lyons +2 more
wiley +1 more source

